Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zoetis
(NY:
ZTS
)
118.65
-1.76 (-1.46%)
Official Closing Price
Updated: 4:10 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zoetis
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
How Do Investors Really Feel About Zoetis?
↗
September 23, 2025
Via
Benzinga
Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results
September 23, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Inc (NYSE:ZTS) Demonstrates Strong Quality Investing Traits in Caviar Cruise Screen
↗
September 23, 2025
Zoetis (ZTS) excels in quality investing with strong revenue growth, a high 48% ROIC, and solid cash flow. Its financial health meets strict Caviar Cruise screening standards for long-term value.
Via
Chartmill
1 S&P 500 Stock Worth Investigating and 2 Facing Headwinds
September 15, 2025
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...
Via
StockStory
Topics
Stocks
Analyst Expectations For Zoetis's Future
↗
September 09, 2025
Via
Benzinga
Earnings Scheduled For August 5, 2025
↗
August 05, 2025
Via
Benzinga
How Do Investors Really Feel About Zoetis?
↗
July 25, 2025
Via
Benzinga
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
September 12, 2025
From
Zoetis Inc.
Via
Business Wire
1 Cash-Producing Stock to Consider Right Now and 2 That Underwhelm
September 11, 2025
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Via
StockStory
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 27, 2025
From
Zoetis Inc.
Via
Business Wire
2 Reasons to Watch ZTS and 1 to Stay Cautious
August 25, 2025
Over the past six months, Zoetis’s shares (currently trading at $156.80) have posted a disappointing 7% loss, well below the S&P 500’s 8.6% gain. This might have investors contemplating their next...
Via
StockStory
Topics
Government
Stocks
World Trade
Winners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks
August 17, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q2, starting with...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises
August 13, 2025
Animal health company Zoetis (NYSE:ZTS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around...
Via
StockStory
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
↗
August 12, 2025
Dip into a beaten-down market sector for deals on some proven winners.
Via
The Motley Fool
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
August 11, 2025
From
Zoetis Inc.
Via
Business Wire
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today
↗
August 11, 2025
The short-term picture has been less rosy than the longer-term one.
Via
The Motley Fool
3 Large-Cap Stocks with Promising Prospects
August 11, 2025
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...
Via
StockStory
2 Stocks to Buy With $5,000 and Hold for a Decade
↗
August 10, 2025
These two stocks come from completely different industries, but each could boost a long-term investor's returns.
Via
The Motley Fool
Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday?
↗
August 05, 2025
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc.
Via
Benzinga
Topics
Economy
Government
Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline
↗
August 05, 2025
Zoetis beats Q2 estimates with strong pet product sales and raises full-year guidance despite livestock sales decline and Librela weakness.
Via
Benzinga
Zoetis Surges After Crushing Expectations And Raising Its Outlook
↗
August 05, 2025
The company raised its adjusted profit guidance by 10 cents at the midpoint and hiked its sales guide by $25 million.
Via
Investor's Business Daily
Discover the top S&P500 movers in Tuesday's pre-market session.
↗
August 05, 2025
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Via
Chartmill
Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars
August 05, 2025
Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue...
Via
StockStory
1 Top Dividend Growth Stock to Buy and Hold Forever
↗
August 05, 2025
The demand for this company's products will continue increasing.
Via
The Motley Fool
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook
August 05, 2025
From
Zoetis Inc.
Via
Business Wire
IDEXX Laboratories Soars: A New Benchmark for Animal Health Diagnostics
August 04, 2025
IDEXX Laboratories (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, has sent ripples through the financial markets with an astounding 27.5% surge in its stock price. This...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Zoetis (ZTS) Reports Earnings Tomorrow: What To Expect
August 03, 2025
Animal health company Zoetis (NYSE:ZTS) will be announcing earnings results this Tuesday morning. Here’s what to expect.
Via
StockStory
Topics
Artificial Intelligence
Government
World Trade
Billionaire Terry Smith Sold Fundsmith's Entire Stake in Apple and 11X'd His Position in a Company Whose Addressable Market Can Hit $149 Billion by 2032
↗
July 25, 2025
The "Warren Buffett of Britain" dumped Buffett's actual No. 1 holding in favor a stock with the legs to run higher.
Via
The Motley Fool
Zoetis (ZTS): Buy, Sell, or Hold Post Q1 Earnings?
July 25, 2025
Over the last six months, Zoetis’s shares have sunk to $153.39, producing a disappointing 11.4% loss - a stark contrast to the S&P 500’s 5.8% gain. This may have investors wondering how to approach the...
Via
StockStory
Topics
Government
Stocks
World Trade
Winners And Losers Of Q1: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks
July 23, 2025
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today